Beclomethasone dipropionate nasal spray in children

Summary

Twenty children with extrinsic perennial allergic rhinitis were treated with inhaled beclomethasone dipropionate, 50 μg into each nostril 4-times daily, for a period of 6 weeks. No change in rhinorrhoea, itching and sneezing was observed after provocation testing but there was a reduction in the swelling and size of turbinates (p<0.005). The daily subjective symptom scores (p<0.01), total eosinophil counts (p<0.03) and serum IgE levels (p<0.04) had significantly decreased after treatment. It is suggested that inhaled beclomethasone dipropionate has a useful role in the management of children with perennial allergic rhinitis.